Monitoring C-Reactive Protein in Biologic Naive Patients With Ulcerative Colitis Undergoing Infliximab Remission Induction Therapy

被引：0
|
作者：
Suzuki, Yasuo
Iwasa, Ryota
Yamada, Akihiro
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1122
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [31] Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (08) : 1218 - +
  • [32] CORRELATION OF FECAL CALPROTECTIN AND C-REACTIVE PROTEIN CONCENTRATIONS WITH CLINICAL OUTCOMES AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING INDUCTION THERAPY WITH ETRASIMOD
    Yarur, Andres J.
    Jairath, Vipul
    Zhang, Jinkun
    Panes, Julian
    Chiorean, Michael V.
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    Cabell, Chris
    Naik, Snehal
    Sandborn, William J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1108 - S1109
  • [33] Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Taxonera, C.
    Estelles, J.
    Fernandez-Blanco, I.
    Merino, O.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Saro, C.
    Garcia-Sanchez, V.
    Gento, E.
    Bastida, G.
    Gisbert, J. P.
    Vera, I.
    Martinez-Montiel, P.
    Garcia-Moran, S.
    Sanchez, M. C.
    Mendoza, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 340 - 348
  • [34] Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program
    Dubinsky, Marla C.
    Magro, Fernando
    Steinwurz, Flavio
    Hudesman, David P.
    Kinnucan, Jami A.
    Ungaro, Ryan C.
    Neurath, Markus F.
    Kulisek, Nicole
    Paulissen, Jerome
    Su, Chinyu
    de Leon, Dario Ponce
    Regueiro, Miguel
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (01) : 51 - 61
  • [35] Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission
    Masaki Wakai
    Ryohei Hayashi
    Shinji Tanaka
    Toshikatsu Naito
    Junko Kumada
    Motonobu Nomura
    Hidehiko Takigawa
    Shiro Oka
    Yoshitaka Ueno
    Masanori Ito
    Kazuaki Chayama
    BMC Gastroenterology, 20
  • [36] Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein?
    Bakkaloglu, Oguz Kagan
    Eskazan, Tugce
    Celik, Sinem
    Kurt, Enes Ali
    Hatemi, Ibrahim
    Erzin, Yusuf
    Celik, Aykut Ferhat
    COLORECTAL DISEASE, 2022, 24 (01) : 77 - 84
  • [37] Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission
    Wakai, Masaki
    Hayashi, Ryohei
    Tanaka, Shinji
    Naito, Toshikatsu
    Kumada, Junko
    Nomura, Motonobu
    Takigawa, Hidehiko
    Oka, Shiro
    Ueno, Yoshitaka
    Ito, Masanori
    Chayama, Kazuaki
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [38] Elevated C-reactive Protein in Anti-TNF-Naive Patients is Associated with Higher Remission Rates
    Sandborn, William
    Colombel, Jean-Frederic
    Castillo, Majin
    Zhou, Qian
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S437 - S437
  • [39] Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy
    Engstrom, Johanna
    Lonnkvist, Maria
    Befrits, Ragnar
    Ljung, Tryggve
    Diaz-Tartera, Hetzel
    Holst, Mikael
    Hellstrom, Per M.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1081 - 1088
  • [40] Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
    De Vos, M.
    Dewit, O.
    D'Haens, G.
    Baert, F.
    Fontaine, F.
    Vermeire, S.
    Franchimont, D.
    Moreels, T.
    Staessen, D.
    Terriere, L.
    Vander Cruyssen, B.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 557 - 562
12345